Search

Your search keyword '"Maria G. Vogiatzi"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Maria G. Vogiatzi" Remove constraint Author: "Maria G. Vogiatzi" Language undetermined Remove constraint Language: undetermined
82 results on '"Maria G. Vogiatzi"'

Search Results

2. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents with Congenital Adrenal Hyperplasia

Catalog

Books, media, physical & digital resources

4. Allometric Scaling of Testosterone Enanthate Pharmacokinetics to Adolescent Hypogonadal Males (IM and SC Administration)

5. Approach to the Patient: Central Precocious Puberty

6. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia

7. Skin-to-Skin Care is Associated with Reduced Stress, Anxiety, and Salivary Cortisol and Improved Attachment for Mothers of Infants With Critical Congenital Heart Disease

8. Diagnosis and Management of Endocrine Hypertension in Children and Adolescents

9. Changes in body mass index in children on gonadotropin-releasing hormone agonist therapy with precocious puberty, early puberty or short stature

10. Histrelin implantation in the pediatric population: A 10-year institutional experience

11. Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies

12. Testosterone Use in Adolescent Males: Current Practice and Unmet Needs

13. Crinecerfont (NBI-74788), a novel CRF1 receptor antagonist, reduces adrenal androgens and precursors in patients with classic congenital adrenal hyperplasia: Results from a phase 2, multiple-dose study

14. Skin-to-Skin Care Is a Safe and Effective Comfort Measure for Infants Before and After Neonatal Cardiac Surgery

15. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

16. Behavioral Health Diagnoses in Youth with Differences of Sex Development or Congenital Adrenal Hyperplasia Compared with Controls: A PEDSnet Study

17. Perioperative stress dose steroid management of children with classical congenital adrenal hyperplasia: Too much or too little?

18. Endocrine Management of Ovotesticular DSD, an Index Case and Review of the Literature

19. Adolescent polycystic ovary syndrome according to the international evidence-based guideline

20. Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience

21. SUN-LB064 A Phase 2, Dose-Escalation, Safety and Efficacy Study of Tildacerfont (SPR001) for the Treatment of Patients with Classic Congenital Adrenal Hyperplasia

22. Menstrual Bleeding as a Manifestation of Mini-Puberty of Infancy in Severe Prematurity

23. Health supervision for people with Bloom syndrome

24. Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia

25. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study

26. PCDH19-related epilepsy in a male with Klinefelter syndrome: Additional evidence supporting PCDH19 cellular interference disease mechanism

27. Health-Related Quality of Life in Children with Congenital Adrenal Hyperplasia

28. Vitamin D Supplementation and Risk of Toxicity in Pediatrics: A Review of Current Literature

29. Bone Health in Children and Adolescents With Chronic Diseases That May Affect the Skeleton: The 2013 ISCD Pediatric Official Positions

30. Renal dysfunction in patients with thalassaemia

31. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

32. Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

33. Measurement of bone density in the pediatric population

34. Characteristics of Children with Premature Pubarche in the New York Metropolitan Area

35. Dual-Energy X-ray Aborptiometry Assessment in Children and Adolescents with Diseases that May Affect the Skeleton: The 2007 ISCD Pediatric Official Positions

37. Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia: Pathophysiology, Advances in Management, and Recent Outcomes

38. A General Pediatric Approach to Evaluating a Short Child

39. Final Adult Height in Children With Congenital Adrenal Hyperplasia Treated With Growth Hormone

40. Advances in diagnosis and care of persons with DSD over the last decade

41. Long Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1

42. Growth Hormone Therapy Alone or in Combination with Gonadotropin-Releasing Hormone Analog Therapy to Improve the Height Deficit in Children with Congenital Adrenal Hyperplasia1

43. The Short Child

44. Differential diagnosis and therapeutic options for ambiguous genitalia

45. Effect of ethosuximide on cortisol metabolism in the treatment of congenital adrenal hyperplasia

46. Insulin Does Not Stimulate Protein Synthesis Acutely in Prepubertal Children with Insulin-Dependent Diabetes Mellitus1

47. The effect of vitamin D supplementation on calcium excretion in thalassemia

50. Dehydroepiandrosterone in morbidly obese adolescents: Effects on weight, body composition, lipids, and insulin resistance